News

Filter

Current filters:

ZebinixEisai

Eisai expands deal with Biogen; re-files Fycompa with G-BA; news on Zebinix

Eisai expands deal with Biogen; re-files Fycompa with G-BA; news on Zebinix

12-05-2014

Japanese drug major Eisai has exercised its option to jointly develop and commercialize its clinical…

Biogen IdecEisaiFycompaGermanyItalyLicensingNeurologicalPharmaceuticalPricingRegulationZebinix

Eisai launches Lunesta in Japan, debuts Zebinix in France; opens Dubai office

19-04-2012

Japanese drug major Eisai (TYO: 4523) says it launched the insomnia treatment Lunesta (eszopiclone) in…

Asia-PacificEisaiEuropeLunestaMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldZebinix

Eisai updates on epilepsy drugs Zonegran, Zebinix and perampanel at IEC

31-08-2011

Japanese drug major Eisai (TYO: 4523) presented new data at the International Epilepsy Congress taking…

BIALEisaieslicarbazepineNeurologicalperampanelPharmaceuticalResearchZebinixZonegran

COMPANY SPOTLIGHT

Menarini

Back to top